Small Changes… Big Effects! Breakthrough Therapies Are The Name Of The Game For This Biopharma

  • 21 hours ago
Erez Aminov, CEO & Chairman of the Board, and Dr. Itzchak Angel, Chief Scientific Advisor for MIRA Pharmaceuticals MIRA, were recently interviewed by Benzinga.
MIRA is a pre-clinical biopharma focused on developing treatments for neurologic and neuropsychiatric disorders. It holds exclusive rights to Ketamir-2, an oral ketamine analog being studied for neuropathic pain, treatment-resistant depression, major depressive disorder with suicidal ideation and PTSD. 
The company's other primary asset, MIRA-55, is a novel pharmaceutical marijuana analog that could provide enhanced therapeutic effects over THC.

Category

🗞
News

Recommended

3:08
I
Up next
Total Solar Eclipse Dazzles South America with 'Ring of Fire,' Enthralling Stargazers| Watch Video
Oneindia
3:17
Watch| IDF SHOCKS Iran! 3 Hamas Leaders Killed in Precision Strike, Including Rawhi Mushtaha
Oneindia
3:15
Israeli Missiles Pound Russian Airbase in Syria: Russian and Syrian Army Join Forces as 3 Lives Lost
Oneindia
1:57
Psychiatrists able to prescribe MDMA and psilocybin for PTSD from July
ABC NEWS (Australia)
4:35
What ketamine actually does to your brain
Science Insider
0:44
Warren Buffett-Led Berkshire Hathaway Pares Bank Of America Stake By $338M, Marking 13th Round Of Sales Amid Growing Speculation On Strategic Shifts
Benzinga
0:42
Bank Of America Glitch Leaves Customers Seeing $0 In Accounts — What Happened?
Benzinga
0:41
Cathie Wood-Led Ark Venture Fund Agrees To Invest At Least $250M In OpenAI's Historic Funding Round, ChatGPT-Parent's Now Valued At $157B: Report
Benzinga
0:49
Nancy Pelosi Says JD Vance Was 'Clever' But Not 'Real' On Abortion During The Debate: They Are For A National Ban
Benzinga
0:57
Investors Look To Gold As Middle East Tensions Rise: How Israel-Iran Conflict Could Impact Prices
Benzinga
1:00
MDMA and psychedelic therapy: who can access the newly-available drugs on prescription?
Australian Community Media
10:39
Trying Ketamine To Treat Anxiety
Bustle
1:16
Wall Street's Most Accurate Analysts Spotlight On 3 Defensive Stocks Delivering High-Dividend Yields
Benzinga
1:35
Palantir Stock: Big Data, Big Gains
Benzinga
0:34
Bain Capital Backs Korea Zinc, As World's Largest Zinc Smelter Repurchases Over $2 Billion in Stock to Thwart Hostile Takeover
Benzinga
3:31
The Brain on Drugs: Ketamine
Zoomin English
3:49
Cheap ketamine used as sedative to treat depression
ABC NEWS (Australia)
1:09
Brain Cancer Patients And Cannabis
Healthweed
10:41
Novel Therapy Shows Promising Results In On-Going Trials, Receives 3 Orphan Drug Designations From The FDA
Benzinga
0:40
FDA Approves First Novel Schizophrenia Drug in 70 Years, Impacting Up to 3 Million Patients in the US
Benzinga
0:45
Cybin ($CYBN) Exploring Psilocybin & DMT for Mental Wellness
Benzinga
9:05
Kya Psychiatric Drugs Se Brain Affect Hota Hai? Nuqsan Kya Hai? - Psychiatrist Dr Noman Ahmed
UrduPoint.com
1:58
Dementia At the End of Life: What are the medications?
Healthfeedspanish
0:29
Novartis Skips Weight Loss Drug 'Frenzy,' Focuses on 'Unique Position' for Cancer, Alzheimers, and Parkinsons Treatments
Benzinga
0:43
Please, Please Don't Try This At Home
Wochit Tech